Table 2 Study subject treatment cycles completed
Combination therapy study: utidelone (30 mg/m2/day) + capecitabine (2000 mg/m2/day) n = 33 | Monotherapy study: utidelone (40 mg/m2/day) n = 70 | |
|---|---|---|
Utidelone dose | 30 mg/m2/day for 5 days per cycle | 40 mg/m2/day for 5 days per cycle |
Cycles completed | ||
1 | 1 | 7 |
2 | 5 | 24 |
3 | 2 | 4 |
4 | 4 | 10 |
5 | 3 | 5 |
≥6a | 18 | 20 |
Median | 6 | 3.5 |
Mean | 4.82 | 3.64 |